Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease skin disease
Phenotype C0025202|melanoma
Sentences 1
PubMedID- 22397594 Ipilimumab, marketed as yervoy® by bristol-myers squibb, is the first therapeutic agent which increases survival time in patients with metastatic malignant melanoma, the leading cause of death from skin disease [89].

Page: 1